Biopreservation Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biopreservation Market 

5.1. COVID-19 Landscape: Biopreservation Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biopreservation Market, By Product

8.1. Biopreservation Market Revenue and Volume, by Product, 2024-2033

8.1.1 Equipment

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Media

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Laboratory Information Management System (LIMS)

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Biopreservation Market, By Application

9.1. Biopreservation Market Revenue and Volume, by Application, 2024-2033

9.1.1. Regenerative Medicine

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Bio-banking

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Drug Discovery

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Biopreservation Market, By Cell Providers Volume 

10.1. Biopreservation Market Revenue and Volume, by Cell Providers Volume, 2024-2033

10.1.1. CD19+

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. CD34+

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. iPSC

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. MSC

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Tumor Cells

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

10.1.6. hESC

10.1.6.1. Market Revenue and Volume Forecast (2021-2033)

10.1.7. Others

10.1.7.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Biopreservation Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.4.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.5.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.4.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.5.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.6.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.7.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.4.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.5.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.6.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.7.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.4.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.5.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.6.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.7.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.4.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.5.3. Market Revenue and Volume Forecast, by Cell Providers Volume (2021-2033)

Chapter 12. Company Profiles

12.1. Biomatrica, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Azenta US, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. MVE Biological Solutions

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. BioLife Solutions

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. LabVantage Solutions, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Thermo Fisher Scientific, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Taylor-Wharton

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Panasonic Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. PrincetonCryo

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. X-Therma Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms